Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Immune triggers preceding neuralgic amyotrophy
European Journal of Neurology, 4 ottobre 2024

2) Persistent longitudinal T cell responses after SARS-CoV-2 mRNA vaccines in MS patients on different disease modifying treatments
Multiple Sclerosis and Related Disorders, 6 agosto 2024

3) Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura
Cephalalgia, febbraio 2024

4) Complement Activation Is Associated With Disease Severity in Multiple Sclerosis
Neurology - Neuroimmunology & Neuroinflammation, marzo 2024

5) Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase®
The Journal of Headache and Pain, 19 gennaio 2024

6) Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS
Neurology, 9 gennaio 2024

7) Biometry extraction and probabilistic anatomical atlas of the anterior Visual Pathway using dedicated high-resolution 3-D MRI
Scientific Reports, 3 gennaio 2024

8) Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis
Cem Stell Cem, 21 novembre 2023

9) Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients
European Journal of Neurology, 17 novembre 2023

10) The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain, 2 novembre 2023

11) Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
Frontiers in Neurology, 17 maggio 2023

12) Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
Multiple Sclerosis, 7 aprile 2023

13) Imaging of neuralgic amyotrophy in the acute phase
Muscle & Nerve, dicembre 2022

14) Response to erenumab assessed by Headache Impact Test-6 is modulated by genetic factors and arterial hypertension: An explorative cohort study
European Journal of Neurology, aprile 2023

15) Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
Cephalalgia, aprile 2023

16) Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
Cephalalgia, ottobre 2021

17) Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis
Multiple Sclerosis, ottobre 2020

18) How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis
Multiple Sclerosis, aprile 2020

19) Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience
Multiple Sclerosis, ottobre 2020

20) Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study
Journal of Neurology, gennaio 2020

21) Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
European Journal of Neurology, settembre 2021

22) Improved Assessment of Longitudinal Spinal Cord Atrophy in Multiple Sclerosis Using a Registration-Based Approach: Relevance for Clinical Studies
Journal of Magnetic Resonance Imaging, maggio 2022

23) Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
Multiple Sclerosis, maggio 2022

24) Clinic and genetic predictors in response to erenumab
European Journal of Neurology, aprile 2022

25) Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
Multiple Sclerosis and Related Disorders, febbraio 2022

26) Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
Journal of Neurology, settembre 2022

27) Relationship between cognitive disturbances and sleep disorders in multiple sclerosis is modulated by psychiatric symptoms
Multiple Sclerosis and Related Disorders, agosto 2022

28) Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry
Multiple Sclerosis and Related Disorders, novembre 2022

29) Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
Journal of Neurology Neurosurgery and Psychiatry, gennaio 2023

30) Inclusions in macrophages of the cerebrospinal fluid during treatment with Tofersen
Muscle & Nerve, febbraio 2023

31) Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
JAMA Neurology, 6 febbraio 2023

32) A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients
JMRI Journal of Magnetic Resonance Imaging, 28 gennaio 2023

33) Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
BMJ Neurology Open, 26 gennaio 2023

34) Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Neurology Neuroimmunology & Neuroinflammation, 17 novembre 2022

35) The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
JMIR Medical Informatics, 10 novembre 2022

36) Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis
Scientific Reports, 24 ottobre 2022

37) Reader Response: Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study
Neurology, 18 ottobre 2022

38) Studying Real-World Experiences of Persons with Multiple Sclerosis during the first Covid-19 Lockdown: An Application of Natural Language Processing
JMIR Medical Informatics, 2 ottobre 2022

39) Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES
Multiple Sclerosis Journal, luglio 2022

40) Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
Brain, 27 agosto 2022

41) Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
JAMA Neurology, 1 luglio 2022

42) Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS
Annals of Neurology, giugno 2022

43) Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentials
Clinical Neurophysiology, maggio 2022

44) Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry
Multiple Sclerosis and Related Disorders, aprile 2022

45) Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors
Nature and Science of Sleep, 20 aprile 2022

46) Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
The Lancet Neurology, marzo 2022

47) Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS)
Journal of Central Nervous System Disease, 1 aprile 2022

48) The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources
International Journal of MS Care, novembre-dicembre 2021

49) Leg movement activity during sleep in multiple sclerosis with and without restless legs syndrome
Journal of Clinical Sleep Medicine, 1 gennaio 2022

50) Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
NPJ Parkinson’s Disease, 20 dicembre 2021

51) Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis
JAMA Neurology, 1 dicembre 2021

52) Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Therapeutic Advances in Neurological Disorders, 18 agosto 2021

53) Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing
Frontiers in Neurology, 12 agosto 2021

54) Leg movement activity during sleep in multiple sclerosis with and without RLS
Journal of Clinical Sleep Medicine, 24 giugno 2021

55) Contribution of sleep disturbances to fatigue in ms: a prospective study using clinical and polysomnographic parameters
European Journal of Neurology, 18 giugno 2021

56) Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
Multiple Sclerosis Journal, 14 giugno 2021

57) The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
Brain Sciences, 5 giugno 2021

58) Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database."
Cephalagia, 2 maggio 2021

59) Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves
Journal of the Periferical Nervous System, 21 aprile 2021

60) Intrathecal Immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis
Annals of Neurology, 31 marzo 2021

61) Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis
American Journal of Neuroradiology, 25 marzo 2021

62) Restless Legs Syndrome and Periodic Limb Movements in 86 patients with Multiple Sclerosis
Sleep, 15 marzo 2021

63) A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy
Multiple Sclerosis and Related Disorders, 24 febbraio 2021

64) Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Journal of Psychosomatic Research, 16 febbraio 2021

65) Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
Journal of Clinical Medicine, 26 gennaio 2021

66) Control of Raw Pork Liver Sausage Production Can Reduce the Prevalence of HEV Infection
Pathogens, 22 gennaio 2021

67) Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis
Neurology, 13 gennaio 2021

68) Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
Cephalalgia, 12 gennaio 2021

69) Safety profile of anti-calcitonin gene-related peptide monoclonal antibodies in pregnancy, lactation and fertility: analysis of the WHO global pharmacovigilance database
Reproductive Toxicology, ottobre 2020

70) Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis
Multiple Sclerosis and Related Disorders, 23 dicembre 2020

71) SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting
Heliyon, 23 dicembre 2020

72) Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients
Multiple Sclerosis Journal, 12 novembre 2020

73) Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study
Journal of Neurology, 21 ottobre 2020

74) Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data
Journal of Neurology, https://link.springer.com/article/10.1007/s00415-020-10250-6

75) A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation
Neurology Neuroimmunology & Neuroinflammation, https://nn.neurology.org/content/7/6/e888

76) De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis
Multiple Sclerosis Journal, https://journals.sagepub.com/doi/10.1177/1352458520952036

77) Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study
Multiple Sclerosis Journal, https://journals.sagepub.com/doi/10.1177/1352458520940548

78) Factors Associated With Employment and Expected Work Retention Among Persons With Multiple Sclerosis: Findings of a Cross-Sectional Citizen Science Study
Journal of Neurology, https://link.springer.com/article/10.1007%2Fs00415-020-09973-3

79) Teriflunomide vs Injectable Disease Modifying Therapies for Relapsing Forms of MS
Multiple Sclerosis and Related Disorders, https://www.msard-journal.com/article/S2211-0348(20)30234-0/pdf

80) Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories.
Multiple Sclerosis and Related Disorders, https://www.msard-journal.com/article/S2211-0348(20)30224-8/pdf

81) Framing multiple sclerosis under a polysomnographic perspective
Sleep, 12 marzo 2020

82) 60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments
Frontiers in Neurology, 6 marzo 2020

83) Rebound of disease activity after fingolimod withdrawal: Immunological and gene expression profiling.
Multiple Sclerosis and Related Disorders, https://www.msard-journal.com/article/S2211-0348(20)30003-1/fulltext
Claudio Gobbi
is currently collaborating with
Neurocentro - Istituto di Neuroscienze cliniche della Svizzera italiana (INSI) (Rif. INSI)
Via Tesserete 46
6900 Lugano
Claudio Gobbi
on behalf of
Neurocentro - Istituto di Neuroscienze cliniche della Svizzera italiana (INSI) EOC (Rif. INSI)
is currently participating in the Research Group
Neuromuscular disorders
as Group Leader [Rif. 55110]
Claudio Gobbi
on behalf of
Neurocentro - Istituto di Neuroscienze cliniche della Svizzera italiana (INSI) EOC (Rif. INSI)
is currently participating in the Research Group
Multiple sclerosis
as Group Leader [Rif. 55110]